Mounjaro®
Starting from £179.99/mo
Start journey Learn morePepto-Bismol is not known to interact directly with semaglutide, the active ingredient in Wegovy, and many people use it occasionally for nausea or an upset stomach while on treatment. That said, the picture is more nuanced than a simple yes or no — bismuth subsalicylate has its own effects on the gut, and some of those effects overlap with symptoms Wegovy itself can cause, which is worth understanding before you reach for the pink bottle. As a prescription-only medicine, Wegovy requires ongoing clinical oversight, and any new medicine or remedy you add during treatment is worth raising with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Bismuth subsalicylate (the active compound in Pepto-Bismol) is an antidiarrhoeal and antacid that works mainly within the gut lining. No pharmacokinetic interaction with semaglutide is documented in the NHS medicines information for semaglutide or in current BNF prescribing guidance. In straightforward terms: the two do not appear to block, accelerate or amplify each other's main actions in a clinically meaningful way.
That reassurance has a limit, though. Semaglutide slows gastric emptying, food and anything else you swallow moves through your stomach more slowly than usual. There is a theoretical possibility that this delays absorption of oral medicines taken at the same time, though for Pepto-Bismol, which acts locally inside the gut rather than being absorbed into the bloodstream to do its job, this is unlikely to matter in practice. It is still a reasonable habit to leave a short gap between taking Wegovy and any other oral remedy, and the full picture of what to be cautious with on Wegovy is broader than Pepto-Bismol alone.
One practical note: certain Pepto-Bismol formulations in the UK contain aspirin-related compounds. If you take anticoagulants, have a history of gastric ulcers, or have been told to avoid aspirin, check the label carefully or ask a pharmacist before using any bismuth-salicylate product.
Yes, and this is where the question gets genuinely useful to think through. Nausea, loose stools, indigestion and stomach discomfort are among the most commonly reported side effects during the early weeks of semaglutide treatment, particularly after a dose increase. For most people these settle within a fortnight or so as the body adjusts.
A common misconception is that reaching for an over-the-counter stomach remedy means something has gone wrong with your prescription. It has not. Mild, manageable nausea that you can ease with a standard gut-settling product is a normal feature of the titration phase for many people, it is not a sign to stop treatment or to worry unduly. What does warrant a call to your prescriber is nausea that is severe, persistent beyond a couple of weeks, or accompanied by other symptoms such as sharp upper-abdominal pain that reaches into the back. That last combination in particular (severe stomach pain radiating to the back) is the warning sign the MHRA highlights in connection with acute pancreatitis, a rare but serious complication flagged in a January 2026 Drug Safety Update for GLP-1 medicines. Pepto-Bismol is not the right response to that kind of pain.
Occasional use of Pepto-Bismol for mild symptoms is a different situation from masking a pattern that needs clinical review. If you find yourself using it every few days, that frequency is worth mentioning at your next check-in. Our prescribers field this question regularly, it is not a trivial one.
Several approaches are commonly suggested for GLP-1-related nausea that avoid any overlap concern. Eating slowly, keeping portions smaller, choosing lower-fat foods and staying well hydrated are the first-line options, simple but genuinely effective for most people. Ginger (in tea, tablets or ginger ale with real ginger) has a reasonable evidence base for mild nausea. Plain oral rehydration sachets can help if loose stools have left you feeling depleted.
For nausea specifically, some prescribers suggest antacids such as calcium carbonate preparations (standard over-the-counter antacid tablets) as a lower-complexity option than Pepto-Bismol, since these work neutrally on stomach acid and carry fewer salicylate considerations. Details of what tends to help and what to avoid eating are worth discussing directly with your prescriber or a pharmacist, as individual circumstances vary. If you want a sense of the broader landscape of medicines to be thoughtful about on semaglutide, our guide to medicines and semaglutide interactions covers the key categories.
It is also worth knowing that if gut side effects are proving difficult to manage, dose timing can sometimes be adjusted. That is a clinical decision (not something to change without guidance) but it is a real option that a prescriber can discuss with you.
Self-managing occasional nausea or a brief bout of loose stools with an over-the-counter remedy is reasonable. There are signs, though, that mean the situation needs clinical input rather than a trip to the chemist. Seek help promptly if you experience severe or persistent vomiting, signs of dehydration (dark urine, dizziness, very little output), or any of the pancreatitis warning signs mentioned above. For symptoms you are unsure about, the MHRA's Yellow Card scheme also allows patients to report suspected side effects directly, which contributes to ongoing medicine safety monitoring across the UK.
Before adding anything new (including over-the-counter remedies) to your routine during Wegovy treatment, a quick check with your prescriber is always the safest move. The detailed breakdown of Pepto-Bismol and semaglutide explores the pharmacology in more depth if you want further reading. And if you are still weighing up the cost and practicalities of your treatment overall, our Wegovy pricing guide sets out what legitimate private treatment includes. To talk through any concerns about your current treatment or to start a new consultation, you are welcome to speak to our prescribers at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.